IVF and fertility marketing: a playbook for Indian hospitals
IVF marketing in India is tightly regulated and almost entirely self-pay. Couples research privately for months, compare clinics on trust and cost, and are wary of promises. Win with visible ART Act registration, honest explanations of the process and costs, discreet communication and counsellor-led follow-up. Never advertise sex selection or ‘guaranteed’ results.
Why IVF and fertility marketing is different
A 2026 meta-analysis put infertility among Indian women aged 15 to 49 at about 8%. IVF is excluded from PM-JAY and from standard health insurance, so couples pay themselves and compare carefully. The Assisted Reproductive Technology (Regulation) Act, 2021 now governs clinics, which makes registration and compliance part of the brand.
Key facts for IVF and fertility marketers
| Fact | Figure | Source |
|---|---|---|
| Pooled infertility prevalence, women 15-49 (2026 meta-analysis) | About 8% | Reproductive Health (Springer) |
| ART clinic applications registered (May 2023) | 219 of 4,446 (4.9%) | Journal of Obstetrics and Gynaecology of India |
| PM-JAY coverage | No IVF package in the HBP 2.2 package list | NHA HBP 2.2 manual |
| Commercial surrogacy advertising penalty | Up to 10 years and Rs 10 lakh fine | Surrogacy (Regulation) Act 2021, s.38 |
How patients decide
- Private worry. Couples search quietly, often late at night, about trying to conceive and when to see a specialist.
- First consultation. Tests and a treatment plan; many couples are anxious about cost and success.
- Comparison. They compare clinics on doctor, registration, transparency, cost and reviews, sometimes across cities.
- Treatment cycles. Repeated visits over weeks, often more than one cycle, with high emotional stakes.
- Outcome and after. Pregnancy care handover or counselling about next steps.
Channels that matter most
- Discreet, informative search content answering fertility questions plainly.
- Doctor and embryologist pages with qualifications and ART Act registration shown clearly.
- Search ads for fertility treatment and city terms, sending to pages that explain process and cost honestly.
- Counsellor-led WhatsApp follow-up with explicit consent and discreet message wording.
- Webinars or recorded Q&A with fertility specialists for couples still researching.
Content to publish first
Start with the questions patients and families actually ask. Each of these should open with a short, direct answer and be reviewed by a specialist before it goes live.
- What happens in an IVF cycle, step by step
- What decides the cost of IVF (medicines, procedures, number of cycles)
- Questions to ask before choosing a fertility clinic, including registration
- Coping with the emotional side of fertility treatment
- What the ART Act means for patients and donors
- When to see a fertility specialist
Compliance rules to know
- ART (Regulation) Act, 2021: advertising sex-selective ART is banned (s.32), sex selection is banned (s.26), and sale of gametes or embryos is banned (s.29). Show your National ART and Surrogacy Registry registration.
- PCPNDT Act, 1994 s.22: no advertising of sex determination or selection in any form.
- Surrogacy (Regulation) Act, 2021: advertising commercial surrogacy can draw up to 10 years in prison.
- Drugs and Magic Remedies Act, 1954 lists sterility in women and sexual impotence: no ‘cure’ claims for any drug or remedy.
- Avoid success-rate advertising unless it is your own audited data, defined clearly by age group and cycle type.
These sit on top of the rules that apply to every specialty: the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, which remain in force after the NMC’s 2023 regulations were put in abeyance and treat soliciting patients as unethical; the CCPA’s 2022 guidelines on misleading advertisements; ASCI’s codes, including its 2025 rules for health influencers; and the DPDP Act, 2023 for every enquiry you collect. The regulation section of key statistics 2026 has the enforcement numbers, and DPDP notice and consent covers enquiry data.
Insurance and government schemes
IVF is excluded from PM-JAY and from IRDAI’s standard health insurance wording, so it is almost always self-pay. That makes cost transparency, financing options and honest expectations about the number of cycles central to trust.
What to measure
Judge marketing on outcomes the hospital can verify, not clicks. These are the numbers I would put on a monthly dashboard:
- Consultation-to-cycle conversion
- Time from enquiry to first consultation
- Share of enquiries asking about cost and how fast they get an answer
- Counsellor follow-up completion
- Review and referral rate
The common mistake
Advertising success rates as a headline without defining them. Undefined percentages invite complaints, break trust when results differ, and can breach consumer protection rules.
Questions people ask
Yes, within limits. Clinics can share factual information about services, doctors, registration and process. They must not advertise sex selection, commercial surrogacy, or the sale of gametes or embryos, and should avoid unverified success claims.
Generally no. Assisted reproduction is excluded from PM-JAY packages and from IRDAI’s standard exclusion list for health insurance, so most couples pay themselves. Clinics should explain costs clearly and mention any financing options.
With explicit consent, discreet wording and a named counsellor. Couples value privacy, so avoid revealing message content in previews and never add patients to broadcast lists without permission.
Part of the specialty marketing playbooks series. This guide covers marketing, patient communication and compliance; it is not clinical advice.
Related guides
- Digital marketing for doctors in India: a practical guide
- Healthcare marketing comparisons
- Treatment estimate and payer mix in the glossary
Sources
- Reproductive Health (Springer)
- Journal of Obstetrics and Gynaecology of India
- NHA HBP 2.2 manual
- Surrogacy (Regulation) Act 2021, s.38
Read my takes first in Google Search
